{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:43:19Z","timestamp":1762605799250,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.vhri.2025.101120","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T14:49:37Z","timestamp":1746283777000},"page":"101120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Health-Related Quality of Life in Children With Sickle Cell Anemia in Malaria-Endemic Regions: The Impact of Disease States and Malaria Prevention Strategies"],"prefix":"10.1016","volume":"48","author":[{"given":"Carol","family":"Kamya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Idro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perez","family":"Ochanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Kalibbala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thandile","family":"Nkosi-Gondwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela R.","family":"Akun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamija S.","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiko","family":"O ter Kuile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oddvar","family":"Kaarboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarne","family":"Robberstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vhri.2025.101120_bib1","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"issue":"9861","key":"10.1016\/j.vhri.2025.101120_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"6 suppl 4","key":"10.1016\/j.vhri.2025.101120_bib3","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vhri.2025.101120_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project","volume":"3","author":"McClish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"issue":"23","key":"10.1016\/j.vhri.2025.101120_bib5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"41","key":"10.1016\/j.vhri.2025.101120_bib6","first-page":"2049","article-title":"Quality of life in children with sickle cell disease in Amsterdam area","volume":"143","author":"Kater","year":"1999","journal-title":"Ned Tijdschr Geneesk"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1015332828213","article-title":"Parental report of health-related quality of life in children with sickle cell disease","volume":"25","author":"Palermo","year":"2002","journal-title":"J Behav Med"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1477-7525-8-121","article-title":"Double disadvantage: a case control study on health-related quality of life in children with sickle cell disease","volume":"8","author":"Hijmans","year":"2010","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/jfmpc.jfmpc_444_18","article-title":"The impact of sickle cell anemia on the quality of life of sicklers at school age","volume":"8","author":"Salih","year":"2019","journal-title":"J Fam Med Prim Care"},{"issue":"6","key":"10.1016\/j.vhri.2025.101120_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2141.2005.05500.x","article-title":"Psychological complications in sickle cell disease","volume":"129","author":"Anie","year":"2005","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.vhri.2025.101120_bib11","article-title":"Time to invest in sickle cell anemia as a global health priority","volume":"137","author":"Patrick","year":"2016","journal-title":"Pediatrics"},{"issue":"21","key":"10.1016\/j.vhri.2025.101120_bib12","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/bloodadvances.2018023069","article-title":"Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children","volume":"2","author":"McGann","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/tmi.13506","article-title":"Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019","volume":"26","author":"Hernandez","year":"2021","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485907X154638","article-title":"Sickle cell disease in Africa: burden and research priorities","volume":"101","author":"Makani","year":"2007","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"10.1016\/j.vhri.2025.101120_bib16","first-page":"384","article-title":"Sickle cell disease in Uganda: a time for action","volume":"80","author":"Serjeant","year":"2003","journal-title":"East Afr Med J"},{"key":"10.1016\/j.vhri.2025.101120_bib18","series-title":"Outcomes Assessment in Cancer: Measures, Methods, and Applications","first-page":"14","article-title":"Definitions and conceptual models of quality of life","author":"Ferrans","year":"2005"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2190\/986L-LHQ6-2VTE-YRRN","article-title":"The concepts and principles of equity and health","volume":"22","author":"Whitehead","year":"1992","journal-title":"Int J Health Serv"},{"issue":"4","key":"10.1016\/j.vhri.2025.101120_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0895-4356(98)00179-6","article-title":"Assessing quality of life in clinical research: from where have we come and where are we going?","volume":"52","author":"Wood","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.vhri.2025.101120_bib21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4065\/82.10.1229","article-title":"Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice","volume":"82","author":"Guyatt","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0973-1075.132622","article-title":"Poor health related quality of life among patients of sickle cell disease","volume":"20","author":"Bhagat","year":"2014","journal-title":"Indian J Palliat Care"},{"issue":"4","key":"10.1016\/j.vhri.2025.101120_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pedhc.2009.12.006","article-title":"Health-related quality of life in children and adolescents with sickle cell disease","volume":"25","author":"Dale","year":"2011","journal-title":"J Pediatr Health Care"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib24","first-page":"890","article-title":"Quality of life in patients with sickle cell disease in Jamaica: rural-urban differences","volume":"8","author":"Asnani","year":"2008","journal-title":"Rural Remote Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4314\/pamj.v8i1.71057","article-title":"Health related quality of life among adolescents with sickle cell disease in Saudi Arabia","volume":"8","author":"Amr","year":"2011","journal-title":"Pan Afr Med J"},{"issue":"10","key":"10.1016\/j.vhri.2025.101120_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29876","article-title":"Health-related quality of life of patients with sickle cell disease aged 8-17 years at Kamuzu Central Hospital, Malawi","volume":"69","author":"Wachepa","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12878-019-0141-8","article-title":"Health-related quality of life of adolescents with sickle cell disease in sub-Saharan Africa: a cross-sectional study","volume":"19","author":"Kambasu","year":"2019","journal-title":"BMC Hematol"},{"issue":"9","key":"10.1016\/j.vhri.2025.101120_bib28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/MPH.0b013e31817e4a44","article-title":"The performance of the PedsQLTM Generic Core Scales in children with sickle cell disease","volume":"30","author":"Panepinto","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1348\/135910702760213724","article-title":"The psychosocial experience of people with sickle cell disease and its impact on quality of life: qualitative findings from focus groups","volume":"7","author":"Thomas","year":"2002","journal-title":"Br J Health Psychol"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/adc.75.3.199","article-title":"Pain, quality of life, and coping in sickle cell disease","volume":"75","author":"Fuggle","year":"1996","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.vhri.2025.101120_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5581\/1516-8484.20130093","article-title":"Sociodemographic aspects and quality of life of patients with sickle cell anemia","volume":"35","author":"Santos","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11136-008-9412-8","article-title":"Impact of family income and sickle cell disease on the health-related quality of life of children","volume":"18","author":"Panepinto","year":"2009","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2141.2005.05622.x","article-title":"Health-related quality of life in children with sickle cell disease: child and parent perception","volume":"130","author":"Panepinto","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/pbc.24176","article-title":"Health-related quality of life in sickle cell disease: past, present, and future","volume":"59","author":"Panepinto","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jech.2005.039792","article-title":"Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study","volume":"60","author":"von Rueden","year":"2006","journal-title":"J Epidemiol Community Health"},{"year":"2017","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","key":"10.1016\/j.vhri.2025.101120_bib36"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-023-07274-4","volume":"24","author":"Nkosi-Gondwe","year":"2023","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","author":"Group","year":"1990","journal-title":"Health Policy"},{"year":"2020","series-title":"Methods for Analysing and Reporting EQ-5D Data","author":"Devlin","key":"10.1016\/j.vhri.2025.101120_bib39"},{"issue":"suppl 2","key":"10.1016\/j.vhri.2025.101120_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40273-022-01190-2","article-title":"Value set for the EQ-5D-Y-3L in Hungary","volume":"40","author":"Rencz","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.vhri.2025.101120_bib42","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jval.2020.03.019","article-title":"Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary","volume":"23","author":"Rencz","year":"2020","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2025.101120_bib43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"Van Hout","year":"2012","journal-title":"Value Health"},{"year":"2010","series-title":"Medical Statistics: A Textbook for the Health Sciences","author":"Campbell","key":"10.1016\/j.vhri.2025.101120_bib44"},{"issue":"6","key":"10.1016\/j.vhri.2025.101120_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/heapol\/czl029","article-title":"Constructing socio-economic status indices: how to use principal components analysis","volume":"21","author":"Vyas","year":"2006","journal-title":"Health Policy Plan"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib46","first-page":"115","article-title":"Estimating wealth effects without expenditure data\u2014or tears: an application to educational enrollments in states of India","volume":"38","author":"Filmer","year":"2001","journal-title":"Demography"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s41669-017-0049-9","article-title":"Direct mapping of the QLQ-C30 to EQ-5D preferences: a comparison of regression methods","volume":"2","author":"Crott","year":"2018","journal-title":"Pharmacoecon Open"},{"year":"2015","series-title":"StataCorp Stata Statistical Software","author":"StataCorp","key":"10.1016\/j.vhri.2025.101120_bib49"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-015-0380-8","article-title":"Health-related quality of life in patients with sickle cell disease in Saudi Arabia","volume":"13","author":"Ahmed","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10.1016\/j.vhri.2025.101120_bib51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/pbc.25503","article-title":"Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: a cross sectional study","volume":"62","author":"Adeyemo","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.vhri.2025.101120_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-017-0700-2","article-title":"Determining the longitudinal validity and meaningful differences in HRQL of the PedsQLTM Sickle Cell Disease Module","volume":"15","author":"Panepinto","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10.1016\/j.vhri.2025.101120_bib53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jpepsy\/jss051","article-title":"Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease","volume":"37","author":"Schlenz","year":"2012","journal-title":"J Pediatr Psychol"},{"issue":"2","key":"10.1016\/j.vhri.2025.101120_bib54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/bjhp.12099","article-title":"Assessing the quality of life of children with sickle cell anaemia using self-, parent-proxy, and health care professional-proxy reports","volume":"20","author":"Constantinou","year":"2015","journal-title":"Br J Health Psychol"},{"issue":"3","key":"10.1016\/j.vhri.2025.101120_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pbc.22497","article-title":"Health-related quality of life in children with sickle cell disease: A report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium","volume":"55","author":"Dampier","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.vhri.2025.101120_bib56","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1108\/IJHCQA-01-2013-0008","article-title":"Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not","volume":"27","author":"Nwenyi","year":"2014","journal-title":"Int J Health Care Qual Assur"},{"issue":"12","key":"10.1016\/j.vhri.2025.101120_bib57","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2165\/00019053-200624120-00005","article-title":"Generic health-related quality-of-life assessment in children and adolescents","volume":"24","author":"Ravens-Sieberer","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.vhri.2025.101120_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30691","article-title":"Impact of hospitalization for vaso-occlusive crisis on health-related quality of life in children with sickle cell disease","volume":"70","author":"Vuong","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.vhri.2025.101120_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001274","article-title":"Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease","volume":"2","author":"Anie","year":"2012","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/bloodadvances.2019000128","article-title":"Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis","volume":"4","author":"Esham","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-4-59","article-title":"Hydroxyurea and sickle cell anemia: effect on quality of life","volume":"4","author":"Ballas","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.vhri.2025.101120_bib62","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","article-title":"Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children","volume":"122","author":"Strouse","year":"2008","journal-title":"Pediatrics"},{"issue":"24","key":"10.1016\/j.vhri.2025.101120_bib63","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.vhri.2025.101120_bib64","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1509150","article-title":"Dihydroartemisinin\u2013piperaquine for the prevention of malaria in pregnancy","volume":"374","author":"Kakuru","year":"2016","journal-title":"N Engl J Med"},{"issue":"10179","key":"10.1016\/j.vhri.2025.101120_bib65","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","article-title":"Monthly sulfadoxine\u2013pyrimethamine versus dihydroartemisinin\u2013piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial","volume":"393","author":"Kajubi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vhri.2025.101120_bib66","article-title":"Weekly dihydroartemisinin\u2013piperaquine versus monthly sulfadoxine\u2013pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial","author":"Idro","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vhri.2025.101120_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5 D-5 L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:34:54Z","timestamp":1762605294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":64,"alternative-id":["S2212109925000457"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101120","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-Related Quality of Life in Children With Sickle Cell Anemia in Malaria-Endemic Regions: The Impact of Disease States and Malaria Prevention Strategies","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101120"}}